Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.

Almyroudis NG, Segal BH.

Expert Rev Anti Infect Ther. 2010 Dec;8(12):1451-66. doi: 10.1586/eri.10.141. Review.

PMID:
21133669
2.

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.

Cornely OA, Ullmann AJ, Karthaus M.

Blood. 2003 May 1;101(9):3365-72. Epub 2002 Aug 29. Review.

3.

Role of new antifungal agents in prophylaxis of mycoses in high risk patients.

van Burik JA.

Curr Opin Infect Dis. 2005 Dec;18(6):479-83. Review.

PMID:
16258319
4.

Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.

Segal BH, Almyroudis NG, Battiwalla M, Herbrecht R, Perfect JR, Walsh TJ, Wingard JR.

Clin Infect Dis. 2007 Feb 1;44(3):402-9. Epub 2007 Jan 2.

PMID:
17205448
5.

Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies.

Marr KA.

Curr Opin Infect Dis. 2008 Aug;21(4):409-14. doi: 10.1097/QCO.0b013e328307c7d9. Review.

PMID:
18594294
6.

Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.

McCoy D, Depestel DD, Carver PL.

Pharmacotherapy. 2009 Nov;29(11):1306-25. doi: 10.1592/phco.29.11.1306. Review.

PMID:
19857148
7.

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.

Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC.

Ann Intern Med. 2003 May 6;138(9):705-13.

PMID:
12729424
9.

New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies.

Leather HL, Wingard JR.

Blood Rev. 2006 Sep;20(5):267-87. Epub 2006 Jun 14. Review.

PMID:
16781028
11.

Changing strategies for the management of invasive fungal infections.

Rapp RP.

Pharmacotherapy. 2004 Feb;24(2 Pt 2):4S-28S; quiz 29S-32S. Review.

PMID:
14992487
12.

Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.

Maertens J.

Eur J Haematol. 2007 Apr;78(4):275-82. Epub 2007 Jan 23. Review.

PMID:
17241370
13.

Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.

Rogers TR, Frost S.

Br J Haematol. 2009 Mar;144(5):629-41. doi: 10.1111/j.1365-2141.2008.07412.x. Epub 2008 Dec 11. Review.

PMID:
19120371
14.

Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.

Ziakas PD, Kourbeti IS, Mylonakis E.

Clin Ther. 2014 Feb 1;36(2):292-306.e1. doi: 10.1016/j.clinthera.2013.11.010. Epub 2014 Jan 17.

PMID:
24439393
15.

Antifungal prophylaxis and treatment in patients with hematological malignancies.

Hwang YY, Liang R.

Expert Rev Anti Infect Ther. 2010 Apr;8(4):397-404. doi: 10.1586/eri.10.16. Review.

PMID:
20377335
16.

Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.

Michallet M, Ito JI.

J Clin Oncol. 2009 Jul 10;27(20):3398-409. doi: 10.1200/JCO.2008.20.1178. Epub 2009 Jun 1. Review.

PMID:
19487382
17.

Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.

Kontoyiannis DP.

Bone Marrow Transplant. 2011 Feb;46(2):165-73. doi: 10.1038/bmt.2010.256. Epub 2010 Nov 1. Review.

PMID:
21042306
18.

Antifungal treatment in patients with cancer.

Viscoli C, Castagnola E, Machetti M.

J Intern Med Suppl. 1997;740:89-94. Review.

PMID:
9350188
19.

Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.

Bow EJ, Laverdière M, Lussier N, Rotstein C, Cheang MS, Ioannou S.

Cancer. 2002 Jun 15;94(12):3230-46.

20.

The current role of amphotericin B lipid complex in managing systemic fungal infections.

Chu P, Sadullah S.

Curr Med Res Opin. 2009 Dec;25(12):3011-20. doi: 10.1185/03007990903379077. Review.

PMID:
19849324

Supplemental Content

Support Center